Bristol Myers Squibb Archives - Page 2 of 4 - Express Pharma

Alembic Pharma receives US FDA tentative approval for Dasatinib tablets

US FDA approves expanded use of Bristol Myers cancer drug Opdivo

US FDA accepts Bristol Myers Squibb’s application for Orencia for priority review

EMA validates Bristol Myers Squibb’s two Opdivo-based applications to treat cell carcinoma

Syngene extends research partnership with Bristol Myers Squibb until 2030

Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat relapsed or refractory multiple myeloma

Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene

Bristol Myers Squibb get EC approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with chemotherapy for metastatic NSCLC

Bristol Myers Squibb presents data from True North trial of Zeposia (ozanimod) for ulcerative colitis

Bristol Myers Squibb gets US FDA approval for Opdivo + Yervoy to treat unresectable MPM